Instituto Bernabeu participates in the EBART 2026 international congress in Barcelona

Instituto Bernabeu has participated in the sixth edition of EBART 2026 (Evidence Based Assisted Reproduction Technology), held on April 23 and 24 in Barcelona. This international meeting, organized by the Eugin Group, brings together experts in reproductive medicine to address the most recent advances in assisted reproduction based on scientific evidence.

This congress, focused on the future of assisted reproduction technologies, addressed key issues such as ovarian stimulation, artificial intelligence applied to clinical practice, reproductive genetics, and new challenges in embryology.

Participation in leading scientific sessions

Dr. Andrea Bernabeu, medical director of Instituto Bernabeu, participated as the moderator of the session “Challenges in ovarian stimulation and luteal phase” held on April 23. This session analyzed the main current challenges in ovarian stimulation and the management of the luteal phase within assisted reproduction treatments.

Furthermore, Dr. Belén Lledó, director of Instituto Bernabeu Biotech, took part as a speaker in the session “Genetics and ART: genetic testing at every step”. She presented the paper titled “Preconceptional genetic screening: leveraging genetics and artificial intelligence,” focusing on the role of genetics and artificial intelligence in pre-conception studies.

An international forum to advance reproductive medicine

The EBART congress has established itself as a leading space for the exchange of knowledge among specialists, promoting reproductive medicine based on evidence, technological innovation, and a patient-centered approach.

The participation of Instituto Bernabeu in these types of meetings reinforces its commitment to research and the incorporation of the latest scientific advances into clinical practice, with the goal of continuing to offer more precise and personalized treatments.